Cormorant Asset Management, LP - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 228 filers reported holding SORRENTO THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cormorant Asset Management, LP ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$3,052,000
-37.0%
400,000
-20.0%
0.12%
-24.8%
Q2 2021$4,845,000
-78.7%
500,000
-81.8%
0.16%
-67.5%
Q1 2021$22,742,000
-26.0%
2,750,000
-38.9%
0.51%
-30.6%
Q4 2020$30,713,000
-57.6%
4,500,000
-30.8%
0.73%
-73.8%
Q3 2020$72,475,000
+77.5%
6,500,0000.0%2.79%
+78.8%
Q2 2020$40,820,000
+343.7%
6,500,000
+30.0%
1.56%
+264.9%
Q1 2020$9,200,000
-32.0%
5,000,000
+25.0%
0.43%
-20.9%
Q4 2019$13,520,000
+299.8%
4,000,000
+136.6%
0.54%
-3.7%
Q2 2017$3,382,000
-49.4%
1,690,8000.0%0.56%
-42.2%
Q1 2017$6,679,000
-28.6%
1,690,800
-11.4%
0.97%
-23.1%
Q4 2016$9,354,000
-43.0%
1,909,000
-10.0%
1.26%
-30.3%
Q3 2016$16,417,000
+38.2%
2,121,0130.0%1.81%
+7.5%
Q2 2016$11,878,000
+5.4%
2,121,013
+1.2%
1.68%
-0.8%
Q1 2016$11,273,000
-38.2%
2,095,3340.0%1.70%
-22.2%
Q4 2015$18,250,000
+3.8%
2,095,3340.0%2.18%
-22.3%
Q3 2015$17,580,000
-48.7%
2,095,334
+7.7%
2.81%
-38.4%
Q2 2015$34,277,000
+79.4%
1,945,334
+17.7%
4.56%
+54.3%
Q1 2015$19,108,000
+8.4%
1,652,912
-5.5%
2.95%
+8.7%
Q4 2014$17,623,000
+289.9%
1,750,000
+75.0%
2.72%
+192.2%
Q3 2014$4,520,000
-33.0%
1,000,0000.0%0.93%
-48.0%
Q2 2014$6,750,000
-24.8%
1,000,000
+42.9%
1.79%
-13.3%
Q1 2014$8,974,000700,0002.06%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 15,001$1,4100.00%
KLCM Advisors, Inc. 20,000$1,8800.00%
AlphaMark Advisors, LLC 3,135$00.00%
TRUST CO OF VERMONT 204$190.00%
SlateStone Wealth, LLC 30,866$30.00%
Coppell Advisory Solutions LLC 100$890.00%
Highlander Capital Management, LLC 1,200$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Russell Investments Group, Ltd. 266$250.00%
OGOREK ANTHONY JOSEPH /NY/ /ADV 3,600$00.00%
View complete list of SORRENTO THERAPEUTICS INC shareholders